CorMedix Revenue and Competitors

Bedminster, NJ USA

Location

#4629

Growjo Ranking

Pharma

Industry

Estimated Revenue & Valuation

  • CorMedix's estimated annual revenue is currently $7.5M per year.(i)
  • CorMedix's estimated revenue per employee is $89,286
  • CorMedix's total funding is $11.5M.

Employee Data

  • CorMedix has 84 Employees.(i)
  • CorMedix grew their employee count by 79% last year.

CorMedix's People

NameTitleEmail/Phone
1
Head Patient Advocacy and Special ProjectsReveal Email/Phone
2
EVP and General CounselReveal Email/Phone
3
Director, Quality SystemsReveal Email/Phone
4
Executive Director Clinical DevelopmentReveal Email/Phone
5
EVP and Chief Commercial OfficerReveal Email/Phone
6
EVP and Chief Financial OfficerReveal Email/Phone
7
Director Quality Assurance & Regulatory AffairsReveal Email/Phone
8
.Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is CorMedix?

Scientific evidence indicates that cardiovascular and kidney disease are inextricably intertwined.CorMedix has two foundational technologies. The first prevents and/or treats cardiorenal diseases by reducing tissue-damaging oxidative stress caused by excess ("labile" or "toxic") iron.

keywords:Biotechnology, Healthcare

$11.5M

Total Funding

84

Number of Employees

$7.5M

Revenue (est)

79%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CorMedix News

2022-04-06 - CorMedix Inc. Announces Scientific Advisory Board to Support ...

CorMedix is focused on preparing for a potential commercial launch in hemodialysis and aims to explore the safety and effectiveness of DefenCath...

2022-03-30 - CorMedix Inc. Reports Fourth Quarter and Full Year 2021 ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of...

2022-03-22 - CorMedix Inc. Announces FDA Acceptance of Resubmission ...

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.8M9221%N/A
#2
$21.4M1026%N/A
#3
$27.1M12312%N/A
#4
$27.1M12322%N/A
#5
$29M138-14%N/A